Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$383M |
| 2 |
Costco
COST
|
+$267M |
| 3 |
Pfizer
PFE
|
+$231M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$227M |
Top Sells
| 1 |
CVS Health
CVS
|
+$258M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL RESOURCES INC (HOLDING CO)
GAS
|
+$216M |
| 4 |
Charter Communications
CHTR
|
+$142M |
| 5 |
TE
TECO ENERGY INC
TE
|
+$136M |
Sector Composition
| 1 | Technology | 15.67% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.63% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Columbus McKinnon
CMCO
$415M
| $715K | ﹤0.01% |
40,085
+9,900
| +33% | +$177K |
|
2702
Calumet Specialty Products
CLMT
$1.51B
| $710K | ﹤0.01% |
+157,400
| New | +$710K |
|
2703
Kodak
KODK
$486M
| $707K | ﹤0.01% |
47,100
+24,800
| +111% | +$372K |
|
|
MRTX
2704
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $706K | ﹤0.01% |
106,800
-128,920
| -55% | -$852K |
|
2705
EVI Industries
EVI
$348M
| $703K | ﹤0.01% |
86,400
-700
| -0.8% | -$5.7K |
|
|
HTM
2706
DELISTED
U.S. Geothermal Inc.
HTM
| $701K | ﹤0.01% |
161,267
+27,309
| +20% | +$119K |
|
|
PSG
2707
DELISTED
Performance Sports Group Ltd.
PSG
| $701K | ﹤0.01% |
172,653
+100,053
| +138% | +$406K |
|
|
SWIR
2708
DELISTED
Sierra Wireless
SWIR
| $699K | ﹤0.01% |
+48,484
| New | +$699K |
|
|
ERF
2709
DELISTED
Enerplus Corporation
ERF
| $698K | ﹤0.01% |
108,857
-360,800
| -77% | -$2.31M |
|
2710
Regions Financial
RF
$24.2B
| $692K | ﹤0.01% |
70,121
-3,079,753
| -98% | -$30.4M |
|
2711
Selective Insurance
SIGI
$4.81B
| $690K | ﹤0.01% |
17,300
-89,600
| -84% | -$3.57M |
|
2712
Destination XL Group
DXLG
$80.3M
| $689K | ﹤0.01% |
159,100
-18,800
| -11% | -$81.4K |
|
2713
Adecoagro
AGRO
$806M
| $687K | ﹤0.01% |
60,200
-1,177,000
| -95% | -$13.4M |
|
|
SIEN
2714
DELISTED
Sientra, Inc.
SIEN
| $681K | ﹤0.01% |
+7,580
| New | +$681K |
|
|
MATN
2715
DELISTED
Mateon Therapeutics, Inc.
MATN
| $679K | ﹤0.01% |
1,094,900
+49,100
| +5% | +$30.4K |
|
|
PACD
2716
DELISTED
Pacific Drilling S A
PACD
| $678K | ﹤0.01% |
166,890
+44,900
| +37% | +$182K |
|
|
WHLR
2717
Wheeler Real Estate Investment Trust
WHLR
$5.49M
| – | – |
0
| – | -$421K |
|
|
GI
2718
DELISTED
EndoChoice Holdings, Inc.
GI
| $678K | ﹤0.01% |
84,900
-26,100
| -24% | -$208K |
|
|
GZT
2719
DELISTED
Gazit-globe Ltd
GZT
| $676K | ﹤0.01% |
64,626
+5,226
| +9% | +$54.7K |
|
2720
Workiva
WK
$4.34B
| $674K | ﹤0.01% |
37,200
-20,600
| -36% | -$373K |
|
2721
First US Bancshares
FUSB
$69.1M
| $672K | ﹤0.01% |
63,500
+3,800
| +6% | +$40.2K |
|
2722
Madrigal Pharmaceuticals
MDGL
$9.63B
| $672K | ﹤0.01% |
52,987
-3,187
| -6% | -$40.4K |
|
|
IRD
2723
Opus Genetics, Inc. Common Stock
IRD
$82.7M
| $672K | ﹤0.01% |
6,671
+1,764
| +36% | +$178K |
|
2724
Duluth Holdings
DLTH
$133M
| $671K | ﹤0.01% |
25,300
+11,200
| +79% | +$297K |
|
2725
Aptevo Therapeutics
APVO
$4.83M
| $663K | ﹤0.01% |
+1
| New | +$663K |
|